These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis. Ibbotson GC; Wallace JL Prostaglandins; 1989 Feb; 37(2):237-50. PubMed ID: 2727308 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121 [TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. Hsueh W; González-Crussi F; Arroyave JL FASEB J; 1987 Nov; 1(5):403-5. PubMed ID: 3678700 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury. Chang SW; Fernyak S; Voelkel NF Am J Physiol; 1990 Jan; 258(1 Pt 2):H153-8. PubMed ID: 2301603 [TBL] [Abstract][Full Text] [Related]
7. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Toth PD; Mikulaschek AW Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423 [TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. Wang J; Dunn MJ Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung. Ibbotson GC; Wallace JL J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897 [TBL] [Abstract][Full Text] [Related]
13. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. Kimura K; Moriyama M; Nishisako M; Kannan Y; Shiota M; Sakurada K; Musashi M; Sugano T J Biochem; 1998 Jan; 123(1):142-9. PubMed ID: 9504421 [TBL] [Abstract][Full Text] [Related]
14. Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. Wallace JL; Whittle BJ Eur J Pharmacol; 1986 May; 124(1-2):209-10. PubMed ID: 3720841 [No Abstract] [Full Text] [Related]
15. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation. Li SH; Fei X; Gong XQ; Wu ZL Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797 [TBL] [Abstract][Full Text] [Related]
16. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism. Hatakeyama K; Yano S; Watanabe K Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120 [TBL] [Abstract][Full Text] [Related]
17. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566 [TBL] [Abstract][Full Text] [Related]